Global ClinicalMass Spectrometry Market, by Product Type (Gas chromatography–massspectrometry (GC-MS) instrument, Liquid chromatography–mass spectrometry(LC-MS) instrument, MALDI-TOF mass spectrometer, Capillary electrophoresis–massspectrometry, and Ion mobility spectrometry-mass spectrometry), by Application(Clinical Testing, Proteomics, and Drug discovery), by End User (ResearchLaboratories, Diagnostic Laboratories, and Hospitals), and By Region (North America,Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated tobe valued at US$ 697.2 million in 2019, and is expected to exhibit aCAGR of 5.5% over the forecast period (2019 - 2027). Increasing investments inR&D activities by pharmaceutical companies are driving growth of the globalclinical mass spectrometry market. Mass spectrometry continues to play aprominent role in laboratory medicine. For instance, in 2019, Biotage ABcollaborated with Shandong Yingsheng Biotechnology Co., Ltd to focus onresearch, production and selling in vitro diagnostic reagents and medicalequipment, building a genetic detection platform and mass spectrometrydetection platform around metabolomics and genetics.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/193
As a part of the collaboration,Biotage and Yingsheng agreed to develop clinical mass spectrometry applicationsin China, where Biotage will provide systems and consumables through itsanalytical chemistry portfolio and Yingsheng will sell it with its brand name.Moreover, use of clinical mass spectrometry in laboratory developed tests(LDTs) is driving growth of this market. Properties such as sensitiveanalytical capabilities and enhancements continue to bring the technology tothe edge of new scientific discovery and research applications. Matrix-assistedlaser desorption/ionization - time of flight (MALDI-TOF) have wide applicationin microbiology laboratories. MALDI-TOF systems that have been designated asmedical devices that support FDA-cleared or CE-marked assays. Assays that havereceived FDA clearance or CE-marking over the last few years have largelyrevolved around microbiological identifications with MALDI-TOF. These assaysare different from the majority of the clinical mass spectrometry market, whichis covered by laboratory developed tests (LDTs).
Browse 43 Market Data Tables and33 Figures spread through 169 Pages and in-depth TOC on "Global ClinicalMass Spectrometry Market, by Product Type (Gas chromatography–mass spectrometry(GC-MS) instrument , Liquid chromatography–mass spectrometry (LC- MS)instrument, MALDI-TOF mass spectrometer, Capillary electrophoresis–massspectrometry, and Ion mobility spectrometry-mass spectrometry), by Application(Clinical Testing, Proteomics, and Drug discovery), by End User (ResearchLaboratories, Diagnostic Laboratories, and Hospitals), and By Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa) GlobalForecast to 2027"
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/clinical-mass-spectrometry-market-193
Key Takeaways of the ClinicalMass Spectrometry Market:
The global clinical massspectrometry market is expected to exhibit a CAGR of 5.5% over the forecastperiod (2019 – 2027), owing to technological advancements in mass spectrometryand increasing adoption in laboratory developed tests.
Among region, Asia Pacific isexpected to witness significant growth in the global clinical mass spectrometrymarket over the forecast period, owing to high R&D investment bypharmaceutical companies.
Gas chromatography – massspectrometry (GC-MS) instrument segment held a dominant position in clinicalmass spectrometry market, owing to high adoption of this technology by playersoperating in the market.
Major players operating in theglobal clinical mass spectrometry market include Bruker Corporation, KoreTechnology Limited, Bergman Messgerate Entwicklung KG, Mass SpectrometryInstruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies, andDanaher Corporations.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/193
AboutCoherent Market Insights:
Coherent MarketInsights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
